Bavarian Nordic ramps up monkeypox vaccine production

CEO Paul Chaplin reports that Bavarian is making more doses of its vaccine against monkeypox due to the recent outbreak.
Paul Chaplin, CEO of Bavarian Nordic | Photo: Bavarian Nordic /PR
Paul Chaplin, CEO of Bavarian Nordic | Photo: Bavarian Nordic /PR
by christian bundgaard, translated by daniel pedersen

Bavarian Nordic can currently boast that it is the only firm in the world to have an approved vaccine against infectious disease monkeypox. The current outbreak has turned the spotlight onto the Danish biotech company, which can no longer keep up with demand for its vaccine.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading